Thurman Wheeler
Concepts (77)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Myotonic Dystrophy | 7 | 2006 | 21 |
Why?
|
Trinucleotide Repeat Expansion | 3 | 2006 | 21 |
Why?
|
Oligodeoxyribonucleotides, Antisense | 2 | 2007 | 9 |
Why?
|
RNA | 4 | 2007 | 126 |
Why?
|
RNA-Binding Proteins | 5 | 2006 | 55 |
Why?
|
Alternative Splicing | 4 | 2006 | 51 |
Why?
|
Chloride Channels | 2 | 2007 | 22 |
Why?
|
3' Untranslated Regions | 1 | 2009 | 21 |
Why?
|
Myotonia Congenita | 1 | 2007 | 7 |
Why?
|
Channelopathies | 1 | 2007 | 11 |
Why?
|
Muscle, Skeletal | 4 | 2006 | 114 |
Why?
|
Neuromuscular Junction | 1 | 2007 | 23 |
Why?
|
DNA-Binding Proteins | 2 | 2006 | 204 |
Why?
|
Genetic Predisposition to Disease | 1 | 2007 | 131 |
Why?
|
Protein-Serine-Threonine Kinases | 2 | 2007 | 105 |
Why?
|
Gene Therapy | 2 | 2005 | 89 |
Why?
|
Cell Nucleus | 2 | 2007 | 169 |
Why?
|
Animals | 7 | 2005 | 1031 |
Why?
|
Mice | 5 | 2005 | 623 |
Why?
|
Exons | 2 | 2006 | 91 |
Why?
|
Mice, Transgenic | 2 | 2006 | 209 |
Why?
|
Oligonucleotides | 1 | 2009 | 35 |
Why?
|
RNA Splicing | 2 | 2006 | 42 |
Why?
|
Sarcolemma | 1 | 2007 | 7 |
Why?
|
RNA Splice Sites | 1 | 2007 | 14 |
Why?
|
Actins | 1 | 2009 | 112 |
Why?
|
Cell Line | 2 | 2006 | 375 |
Why?
|
Action Potentials | 1 | 2007 | 77 |
Why?
|
Myotonia | 1 | 2006 | 12 |
Why?
|
RNA Stability | 1 | 2007 | 38 |
Why?
|
Humans | 7 | 1994 | 1856 |
Why?
|
Motor Neurons | 1 | 2007 | 45 |
Why?
|
Mice, Knockout | 1 | 2009 | 265 |
Why?
|
Gene Targeting | 1 | 2005 | 51 |
Why?
|
Muscular Dystrophies | 1 | 2005 | 28 |
Why?
|
Transcription, Genetic | 1 | 2009 | 253 |
Why?
|
Mutation | 2 | 2007 | 340 |
Why?
|
Recombination, Genetic | 1 | 2005 | 78 |
Why?
|
Plasmids | 1 | 2005 | 122 |
Why?
|
RNA, Messenger | 1 | 2009 | 394 |
Why?
|
Prostatic Neoplasms | 2 | 1994 | 120 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 1994 | 14 |
Why?
|
Anticarcinogenic Agents | 1 | 1994 | 8 |
Why?
|
Tumor Markers, Biological | 1 | 1994 | 112 |
Why?
|
Mice, Inbred C57BL | 2 | 2005 | 318 |
Why?
|
Myoblasts | 1 | 2009 | 17 |
Why?
|
Oligonucleotides, Antisense | 1 | 2009 | 46 |
Why?
|
Gene Silencing | 1 | 2009 | 32 |
Why?
|
Models, Genetic | 1 | 2009 | 90 |
Why?
|
Alleles | 1 | 2009 | 108 |
Why?
|
RNA Interference | 1 | 2009 | 75 |
Why?
|
Dystrophin | 1 | 2005 | 7 |
Why?
|
Protein Isoforms | 1 | 2006 | 86 |
Why?
|
Integrases | 1 | 2005 | 36 |
Why?
|
Electromyography | 1 | 2006 | 55 |
Why?
|
RNA Precursors | 1 | 2006 | 21 |
Why?
|
Prostate-Specific Antigen | 2 | 1994 | 34 |
Why?
|
Predictive Value of Tests | 2 | 1994 | 321 |
Why?
|
Disease Models, Animal | 1 | 2006 | 349 |
Why?
|
DNA | 1 | 2005 | 262 |
Why?
|
Gene Expression Regulation | 1 | 2005 | 277 |
Why?
|
Time Factors | 1 | 2005 | 896 |
Why?
|
Capillaries | 1 | 1996 | 47 |
Why?
|
Biopsy, Needle | 1 | 1996 | 94 |
Why?
|
Neoplasm Staging | 1 | 1996 | 125 |
Why?
|
Ploidies | 1 | 1994 | 20 |
Why?
|
Logistic Models | 1 | 1996 | 251 |
Why?
|
DNA, Neoplasm | 1 | 1994 | 75 |
Why?
|
Receptor, erbB-2 | 1 | 1994 | 25 |
Why?
|
Neovascularization, Pathologic | 1 | 1994 | 64 |
Why?
|
Algorithms | 1 | 1996 | 226 |
Why?
|
Mass Screening | 1 | 1994 | 125 |
Why?
|
Prognosis | 1 | 1994 | 388 |
Why?
|
Retrospective Studies | 1 | 1996 | 653 |
Why?
|
Male | 2 | 1994 | 1553 |
Why?
|
Aged | 1 | 1996 | 988 |
Why?
|
Middle Aged | 1 | 1996 | 1161 |
Why?
|
